Section 840.200  Adverse Pregnancy Outcome

An adverse pregnancy outcome for an infant consists of one or more of the following case criterion:

a)         A diagnosis of a birth defect, made prenatally or by two years of age;.

b)         A birth weight of less than 1500 grams;

c)         A diagnosis of fetal alcohol syndrome (ICD-9-CM 760.71);

d)         A fetal or neonatal death; or

e)         A diagnosis of one of the following conditions made prior to discharge from the newborn hospitalization:

1)         Positive toxicology for any controlled substance or a diagnosis of signs of drug toxicity or withdrawal;

2)         Serious infections:

A)        Prenatal exposure to syphilis (V01.6) or a diagnosis of congenital syphilis (ICD-9-CM 090.0-090.9);

B)        Prenatal exposure to hepatitis B (ICD-9-CM V01.7);

C)        Prenatal exposure to chlamydia (V01.8) or a diagnosis of a chlamydial infection (ICD-9-CM 079.88 or 079.98);

D)        Prenatal exposure to herpes (V01.8) or a diagnosis of congenital herpes (ICD-9-CM 771.2);

E)         Group B streptococcus (ICD-9-CM 041.02);

F)         Gonococcal conjunctivitis (neonatorum) (ICD-9-CM 098.40);

G)        Congenital listeriosis (ICD-9-CM 771.2);

H)        Congenital rubella (ICD-9-CM 771.0);

I)          Congenital cytomegalovirus (ICD-9-CM 771.1);

J)         Tetanus neonatorum (ICD-9-CM 771.3);

K)        Septicemia of the newborn (ICD-9-CM 771.81); or

L)         Other congenital infections (ICD-9-CM 771.0-771.81).

3)         Endocrine, metabolic or immune disorder:

A)        Hypothyroidism (ICD-9-CM 243);      

B)        Adrenogenital syndrome (ICD-9-CM 255.2);

C)        Inborn errors of metabolism (ICD-9-CM 270-273, 275-276);

D)        Cystic fibrosis (ICD-9-CM 277.0); or

E)         Immune deficiency disorder (ICD-9-CM 279).

4)         Blood disorder:

A)        Leukemia (ICD-9-CM 204-208);

B)        Hereditary hemolytic anemias (ICD-9-CM 282);

C)        Constitutional aplastic anemia (ICD-9-CM 284); or

D)        Coagulation defects (ICD-9-CM 286).

5)         Other conditions:

A)        Neurofibromatosis (ICD-9-CM 237.7);

B)        Cerebral lipidoses (ICD-9-CM 330.1);

C)        Retinopathy of prematurity (ICD-9-CM 362.21);

D)        Chorioretinitis (ICD-9-CM 363.2);

E)         Strabismus (ICD-9-CM 378);

F)         Endocardial fibroelastosis (ICD-9-CM 425.3);

G)        Occlusion of cerebral arteries (ICD-9-CM 434);

H)        Bronchopulmonary dysplasia (ICD-9-CM 770.7);

I)          Intrauterine growth retardation (ICD-9-CM 764.9);

J)         Intraventricular hemorrhage grade III (ICD-9-CM 772.13);

K)        Intraventricular hemorrhage grade IV (ICD-9-CM 772.14);

L)         Seizures (ICD-9-CM 779.0); or

M)       Other conditions leading to more than 48 hours on a ventilator (ICD-9-CM V46.1).

AGENCY NOTE:  The products of induced abortions shall not be reported to APORS.  ICD-9-CM codes will be supplanted with ICD-10 codes when the latter is adopted by the U.S. Department of Health and Human Services.

(Source:  Amended at 31 Ill. Reg. 12207, effective August 2, 2007)